Abstract
Hemorrhage is considered the most preventable cause of in-hospital deaths worldwide, especially in the acute exsanguinating trauma setting. All the substantial bleeding patients in acute scenarios such as trauma, major surgery, gastrointestinal (GI) tract hemorrhage, aortic aneurysmal rupture, and postpartum hemorrhage (PPH) represent a major challenge of the daily practical activity of anesthesiologists and intensivists, both with surgeons and/or interventional radiologists, facing possible life-threatening blood loss, coagulation derangements, metabolic disorders, and finally, complex profound microcirculation and tissue disorders. The management of bleeding in these patients involves outstanding clinical aspects, requiring a pathophysiological and, possibly, a clinicopathological approach. Acidemia, hypothermia, and low calcium levels all play a pivotal role in persistent coagulopathy in massively bleeding patients. Less than prior fluid administration seeks to minimize overloads resulting in tissue edema and organ failure, dilutional coagulopathy, and coagulation interferences including the “popping the clot” effect, endothelial damage with resulting glycocalyx shedding with effects on increased permeability and interstitial edema, and activation of both inflammatory and coagulation systems with very similar consequences like those observed in sepsis state. Rapid identification of patients who are actively bleeding and need early activation and treatment adopting a massive transfusion protocol in the first hours represents the main objectives of the entire working team. To restore physiology and homeostasis, in parallel with hemostatic control as soon as possible, represents the primary care project of all the involved specialists managing a critical bleeding patient within a first-line position and partnership like blood bankers, beyond trauma surgeons and the other specialists always at work in the emergency department, in order to ameliorate the trauma team as well and to manage such a precious resource as blood and blood components.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cothren CC, Moore EE, Hedegaard HB, et al. Epidemiology of urban trauma deaths: a comprehensive reassessment 10 years later. World J Surg. 2007;31(7):1507–11.
Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269–76.
Hargestam M, Hultin M, Brulin C, et al. Trauma team leaders’ non-verbal communication: video registration during trauma team training. Scand J Trauma Resusc Emerg Med. 2016;24:37–49.
Leenstra NF, Jung OC, Johnson A, et al. Taxonomy of trauma leadership skills: a framework for leadership training and assessment. Acad Med. 2016;91:272–81.
Shapiro MB, Jenkins DH, Schwab CW, et al. Damage control: collective review. J Trauma. 2000;49(5):969–78.
Bogert JN, Harvin JA, Cotton BA. Damage control resuscitation. J Intensive Care Med. 2016;31(3):177–86.
Simmons RL, Collins JA, Heisterkamp CA, et al. Coagulation disorders in combat casualties I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Ann Surg. 1969;169(4):455–82.
McLaughlin DF, Niles SE, Salinas J, et al. A predictive model for massive transfusion in combat casualty patients. J Trauma. 2008;64(2 Suppl):S57–63.
Levy JH, Faraoni D, Sniecinski RM. Perioperative coagulation management in the intensive care unit. Curr Opin Anesthesiol. 2013;26:65–70.
Kozek-Langenecker SA. Coagulation and transfusion in the postoperative bleeding patient. Curr Opin Crit Care. 2014;20:460–6.
Nascimento B, Callum J, Tien H, et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ. 2013;185(12):583–9.
Tapia NM, Chang A, Norman M, et al. TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg. 2013;74(2):378–85.
Ho AM, Holcomb JB, Ng CS, et al. The traditional vs “1:1:1” approach debate on massive transfusion in trauma should not be treated as a dichotomy. Am J Emerg Med. 2015;33(10):1501–4.
Schultz W, McConachie I. Vital signs after haemorrhage—caution is appropriate. Trends Anaesth Crit Care. 2015;5:89–92.
Shen T, Baker K. Venous return and clinical hemodynamics: how the body works during acute hemorrhage. Adv Physiol Educ. 2015;39:267–71.
Kalla M, Herring N. Physiology of shock and volume resuscitation. Surgery. 2013;31(11):545–51.
Rady MY, Kirkman E, Cranley J, et al. Nociceptive somatic nerve stimulation and skeletal muscle injury modify hemodynamics and oxygen transport and utilization after resuscitation from haemorrhage. Crit Care Med. 1996;24(4):623–30.
Jacobsen J, Secher NH. Heart rate during haemorrhagic shock. Clin Physiol. 1992;12(6):659–66.
Kirkman E, Watts S. Haemodynamic changes in trauma. Br J Anaesth. 2014;113(2):266–75.
Tachon G, Harrois A, Tanaka S, et al. Microcirculatory alterations in traumatic hemorrhagic shock. Crit Care Med. 2014;42:1433–41.
Dubin A, Pozo MO, Ferrara G, et al. Systemic and microcirculatory responses to progressive hemorrhage. Intensive Care Med. 2009;35:556–64.
Libert N, Harrois A, Duranteau J. Haemodynamic coherence in haemorrhagic shock. Best Pract Res Clin Anaesthesiol. 2016;30:429–35.
Cohen MJ, Brohi K, Calfee CS, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care. 2009;13:R174.
Manson J, Thiemermann C, Brohi K. Trauma alarmins as activators of damage-induced inflammation. Br J Surg. 2012;99(S1):12–20.
Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1–5.
Chang R, Holcomb JB. Optimal fluid therapy for traumatic hemorrhagic shock. Crit Care Clin. 2017;33:15–36.
Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:1243–51.
Chappell D, Jacob M. Role of the glycocalyx in fluid management: small things matter. Best Pract Res Clin Anaesthesiol. 2014;28:227–34.
Advanced Trauma Life Support (ATLS) for doctors. Chicago: American College of Surgeons Committee on Trauma; 2012. http://www.facs.org/trauma/atls/index.html.
Shafi S, Collinsworth AW, Richter KM, et al. Bundles of care for resuscitation from hemorrhagic shock and severe brain injury in trauma patients—translating knowledge into practice. J Trauma Acute Care Surg. 2016;81(4):780–94.
Stephens CT, Gumbert S, Holcomb JB. Trauma-associated bleeding: management of massive transfusion. Curr Opin Anesthesiol. 2016;29:250–5.
White NJ, Ward KR, Pati S, et al. Hemorrhagic blood failure: oxygen debt, coagulopathy, and endothelial damage. J Trauma Acute Care Surg. 2017;82(6S Suppl 1):S41–9.
Emerson CP, Ebert RV. A study of shock in battle casualties: measurements of the blood volume changes occurring in response to therapy. Ann Surg. 1945;122(5):745–72.
Kozar RA, Peng Z, Zhang R, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg. 2011;112(6):1289–95.
Pati S, Wataha K, Menge T, et al. Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cells. Transfusion. 2013;53(Suppl 1):80S–90S.
Johnson JL, Moore EE, Kashuk JL, et al. Effect of blood products transfusion on the development of postinjury multiple organ failure. Arch Surg. 2010;145(10):973–7.
Moore HB, Moore EE, Chapman MP, et al. Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients. J Thromb Haemost. 2015;13(10):1878–87.
Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth. 2010;105(2):116–21.
Morrison JJ, Ross JD, Dubose JJ, et al. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg. 2013;148(3):218–25.
Curry N, Rourke C, Davenport R, et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth. 2015;115(1):76–83.
Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10(7):1342–51.
Nunez TC, Young PP, Holcomb JB. Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma. 2010;68:1498–505.
Shaz BH, Dante CJ, Harris FIS, et al. Transfusion management of trauma patients. Anesth Analg. 2009;108:1760–8.
Johansson PI, Stensballe J, Rosenberg I, et al. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion. 2007;47(4):593–8.
Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20(1):100.
Holcomb JB, del Junco DJ, Fox EE, et al. The prospective, observational, multi-center, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148:127–36.
Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion. 2012;52(suppl 1):65S–79S.
Torres LN, Sondeen JL, Ji L, et al. Evaluation of resuscitation fluids on endothelial glycocalyx, venular blood flow and coagulation function after hemorrhagic shock in rats. J Trauma Acute Care Surg. 2013;75(5):759–66.
Pati S, Matijevic N, Doursout M-F, et al. Protective effects of Fresh Frozen Plasma on vascular endothelial permeability, coagulation and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma. 2010;69:S55–63.
Haywood-Watson RJ, Holcomb JB, Gonzales EA, et al. Modulation of Syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One. 2011;6(8):e23530.
Maegele M, Schochl H, Cohen MJ. An update on the coagulopathy of trauma. Shock. 2014;41:S1, 21–5.
Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121–67.
Noel P, Cashen S, Patel B. Trauma-induced coagulopathy: from biology to therapy. Semin Hematol. 2013;50:259–69.
Ostrowski SR, Johannson P. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg. 2012;73:60–6.
Pierce A, Pittet J-F. Inflammatory response to trauma: implications for coagulation and resuscitation. Curr Opin Anesthesiol. 2014;27(2):246–52.
Johannson P, Stensballe J, Rasmussen LS, et al. A high admission syndecan-1 level, marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254:194–200.
Johansson PI, Stensballe J, Ostrowski SR. Shock induced endotheliopathy (SHINE) in acute critical illness—a unifying pathophysiologic mechanism. Crit Care. 2017;21:25.
Khan S, Allard S, Weaver A, et al. A major haemorrhage protocol improves the delivery of blood component therapy and reduces waste in trauma massive transfusion. Injury. 2013;44(5):587–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bucci, L. (2019). Initial Resuscitation of Hemorrhagic Shock and Massive Transfusion Protocol. In: Aseni, P., De Carlis, L., Mazzola, A., Grande, A.M. (eds) Operative Techniques and Recent Advances in Acute Care and Emergency Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-95114-0_46
Download citation
DOI: https://doi.org/10.1007/978-3-319-95114-0_46
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95113-3
Online ISBN: 978-3-319-95114-0
eBook Packages: MedicineMedicine (R0)